Koru Medical Systems
(NASDAQ) KRMD
Koru Medical Systems Financials at a Glance
Market Cap
$203.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$43.26M
Net Income (TTM)
-$2.28M
EPS (TTM)
-$0.05
P/E Ratio
-90.04
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$4.44
Volume
72,859
Open
$4.43
Price
$4.44
Volume
72,859
Open
$4.43
Previous Close
$4.43
Daily Range
$4.36 - $4.61
52-Week Range
$2.91 - $6.61
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$4.44
Volume
72,859
Open
$4.43
Previous Close
$4.43
Daily Range
$4.36 - $4.61
52-Week Range
$2.91 - $6.61
Estimated Earnings Date
Aug 5, 2026
KRMD News
KRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Koru Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
73
CEO
Linda M. Tharby
Website
www.korumedical.comHeadquarters
Mahwah, NY 10918, US
KRMD Financials
Key Financial Metrics (TTM)
Gross Margin
61.47%
Operating Margin
-5.99%
Net Income Margin
-5.27%
Return on Equity
-13.61%
Return on Capital
-14.47%
Return on Assets
-7.97%
Earnings Yield
-1.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$203.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
45.93M
Volume
72.86K
Avg. Volume
134.28K
Financials (TTM)
Gross Profit
$26.59M
Operating Income
-$2.59M
EBITDA
-$1.47M
Operating Cash Flow
$714.54K
Capital Expenditure
-$578.97K
Free Cash Flow
$135.57K
Cash & ST Invst.
$8.77M
Total Debt
$3.37M
Koru Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.76M
+22.1%
Gross Profit
$7.03M
+16.3%
Gross Margin
59.79%
N/A
Market Cap
$203.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.54M
N/A
Employees
80
N/A
Net Income
-$807.08K
+30.8%
EBITDA
-$609.55K
+35.8%
Quarterly Fundamentals
Total Cash
$8.77M
+0.4%
Total Debt
$3.37M
-9.8%
Accounts Receivable
$6.32M
+0.8%
Inventory
$4.48M
+36.5%
Long Term Debt
$2.82M
-8.3%
Short Term Debt
$548.05K
-16.8%
Return on Assets
-7.97%
N/A
Return on Invested Capital
-13.13%
N/A
Free Cash Flow
-$75.22K
+89.0%
Operating Cash Flow
$14.66K
+106.2%